Blocknomi
Key Takeaways IDEAYA Biosciences unveiled successful Phase 2/3 data for its darovasertib and crizotinib combination in treating metastatic uveal melanoma The experimental combination achieved a median progression-free survival of 6.9…
Related articles
-
ASML (ASML) Stock Rallies as Analysts Boost Targets Following Strong Q1 and Upgraded 2026 Forecast
Blocknomi Published 17.04.2026 09:49
-
WLFI Token Hits All-Time Low Amid World Liberty’s DeFi Lending Controversy
BeInCrypto Published 11.04.2026 20:20
-
Monad Price Analysis: MON Triple Top Structure Concerns Amid 7% Drop
The Crypto Basic Published 17.04.2026 10:08
-
Drift Protocol and KelpDAO Lead April 2026’s Biggest DeFi Exploits
BlockchainReporter Published 21.04.2026 19:00
-
Crypto Clarity bill has 30% chance of passing this year, Wintermute’s Hammond says
CoinDesk Published 11.04.2026 14:00
-
Venom Foundation Calls for Stronger DeFi Protections in New Comprehensive Guide
BlockchainReporter Published 20.04.2026 10:48
-
Bitcoin hits ‘near-term selling pressure’ after rally to $76K: CryptoQuant
Cointelegraph Published 16.04.2026 03:42
-
Bitcoin Could Be Near A Bigger Breakout As Key Metrics Turn, Capriole Founder Says
NewsBTC Published 15.04.2026 13:00